Surging Need for Lowering DNA Sequencing Cost Likely To Escalate Global Whole-Genome Synthesis Market Growth

The whole-genome synthesis is a branch of the synthetic biology domain. Synthetic biology technology possesses the scope to transform the development and mass manufacturing of vaccination, diagnostics, and therapeutics by utilizing the existing engineering techniques built on the genome sequence, lab protocols, algorithms, scientific knowledge, metabolic models, enzyme properties, and sequence annotations. Such vaccines consist of synthetic nucleotide strands that fuel the formation of proteins with the help of a person’s own cells.

A diverse range of applications of synthetic biology is one of the major factors driving the growth of the global whole-genome synthesis market. Furthermore, the growing funding along with the government initiatives to encourage the research and development activities in synthetic biology to innovate unique solutions will further drive the market expansion. The technological advancements and innovations in nanotechnology will help in exploring oligonucleotides synthesis for microarrays. The surging need for lowering the cost of DNA sequencing and synthesizing is likely to further escalate the growth of the global whole-genome synthesis market during the forecast period. However, the emergence of the golden gate cloning method along with the introduction of in vitro recombination-based methods is expected to provide enough thrust for the expansion of whole-genome synthesis in the forthcoming years. The outbreak of Covid-19 all across the globe is expected to positively shape the trajectory of the global market during the forecast period. There is an urgent requirement for immunotherapies and new vaccines to combat such emergency situations.

The global whole-genome synthesis market can be segmented into applications and regions.

By applications, the market can be segmented into pharmaceutical, biotechnology, chemical & specialty chemicals, and the farming sector. The pharmaceutical application segment accounts for the largest share in the global whole-genome synthesis market due to the growing need for whole-genome synthesis in making novel drugs and vaccines. Furthermore, the biotechnology application segment is expected to witness a significant growth rate in forthcoming years due to the rapidly proliferating biotechnology sector.

Get Sample of this Research Report for more Insights –

North America accounts for the largest share in the global whole-genome synthesis market due to the ongoing large-scale research projects that need whole-genome synthesis at various stages in several educational institutes like John Hopkins University.

Some of the significant players in the global whole-genome synthesis market are Icon Genetics, Integrated DNA Technologies, Twist Bioscience, Ansa Biotechnologies, and J. Craig Venter Institute. To cite, Merck in February 2021 partnered with BioNTech. The partnership was aimed to supply lipids for the manufacturing of Pfizer-BioNTech COVID-19 Vaccine.

About Us

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us

Zion Market Research

244 Fifth Avenue, Suite N202

New York, 10001, United States

Tel: +49-322 210 92714

USA/Canada Toll-Free No.1-855-465-4651



Back to news